Skip to main content
BI

BiRed Imaging Inc.

Bired Imaging utilizes patient-specific infrared imaging and numerical simulation to detect and localize breast cancer tumors without radiation or discomfort. This technology provides a non-intrusive, cost-effective adjunct to mammography, enhancing early detection efforts in a disease that affects 12% of women during their lifetime.

Updated 2 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Product

Problem

Mammography, while effective, involves radiation exposure and can be uncomfortable, potentially deterring some women from regular screening. Existing breast cancer detection methods may also lack sensitivity in women with dense breast tissue, leading to delayed diagnoses.

Solution

Bired Imaging offers a non-radiative breast cancer detection and localization method using patient-specific infrared imaging coupled with numerical simulation based on mathematical analysis. This approach analyzes heat patterns in the breast to identify potential tumors without radiation or discomfort. The technology serves as an adjunct to mammography, particularly beneficial for women seeking a non-invasive screening option or those with dense breast tissue where mammography may be less effective. By providing a cost-effective and comfortable screening modality, Bired Imaging aims to improve early detection rates and ultimately enhance breast cancer outcomes.

Target Audience

The primary target audience includes women seeking non-invasive breast cancer screening options, particularly those with dense breast tissue or concerns about radiation exposure from mammography, as well as healthcare providers looking for complementary screening tools.

Features

  • Patient-specific infrared imaging to capture thermal patterns in the breast.
  • Numerical simulation and mathematical analysis to identify potential tumor locations based on heat signatures.
  • Non-radiative and non-intrusive technology, eliminating radiation exposure and discomfort.
  • Cost-effective screening solution compared to traditional methods.
  • Adjunctive screening modality to complement mammography, especially for women with dense breast tissue.
This profile is AI-generated and may contain inaccuracies.